MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$13,722K
EPS
-$0.18
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
9,714
9,373
23,239*
9,073
Acquired in-process research and development, related party
-
-
0*
0
General and administrative
5,645
5,838
6,289*
5,819
Total operating expenses
15,359
15,211
29,527
14,892
Loss from operations
-15,359
-15,211
-29,527*
-14,892
Interest income
1,855
1,514
2,007*
2,037
Foreign currency loss (gain)
6
-25
2*
-33
Total other income (expense)
-
-
2,008*
-
Total other income, net
1,861
1,489
-
2,004
Net loss
-13,498
-13,722
-27,519*
-12,888
Unrealized gain (loss) on marketable securities
-224
-278
138*
151
Comprehensive loss
-13,722
-14,000
-27,382
-12,737
Basic EPS
-0.18
-0.2
-0.404
-0.19
Diluted EPS
-0.18
-0.2
-0.404
-0.19
Basic Average Shares
76,154,071
68,207,313
67,848,066
68,003,248
Diluted Average Shares
76,154,071
68,207,313
67,848,066
68,003,248
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$13,722K
(-58.93%↓ Y/Y)
Interest income
$1,855K
(-14.63%↓ Y/Y)
Foreign currency loss
(gain)
$6K
(103.70%↑ Y/Y)
Net loss
-$13,498K
(-55.76%↓ Y/Y)
Unrealized gain (loss) on
marketable securities
-$224K
(-800.00%↓ Y/Y)
Total other income,
net
$1,861K
(-7.46%↓ Y/Y)
Loss from operations
-$15,359K
(-43.85%↓ Y/Y)
Total operating
expenses
$15,359K
(43.85%↑ Y/Y)
Research and development
$9,714K
(47.74%↑ Y/Y)
General and
administrative
$5,645K
(37.62%↑ Y/Y)
Buy us a coffee
Climb Bio, Inc. (CLYM)
Climb Bio, Inc. (CLYM)